In this three part series we review the practicalities, benefits and potential hazards of each of the currently available and emerging treatment options for MS. In Part 1 we review the history of the development of MS therapies and its connection with the underlying immunobiology of the disease.
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurolog
https://www.ncbi.nlm.nih.gov/pubmed/24993135